CBOE vs ICCC · P/E 24, rev $2.72B vs rev $17.5M
Cboe Global Markets Inc (CBOE) versus ImmuCell Corporation (ICCC) — a side-by-side from cached financials, not a winner call.
Cboe Global Markets Inc (CBOE) is a financial data & stock exchanges company listed on US.
ImmuCell Corporation (ICCC) is a biotechnology company listed on US.
Latest reported CBOE revenue for 2026-06-30 was $2.72B. Net income was $738.8M. CBOE currently screens at market cap $29.50B and trailing P/E 24.1.
Latest reported ICCC revenue for 2026-06-30 was $17.5M. Net income was $3.8M. Revenue was up 69.4% from 2026-03-31 to 2026-06-30. ICCC currently screens at market cap $58.9M.
CBOE currently screens at market cap $29.50B and trailing P/E 24.1. ICCC currently screens at market cap $58.9M.
Not investment advice. Open the CBOE and ICCC stock pages for the full models.
Not investment advice.